These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3755650

  • 1. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Thigpen JT, Blessing JA, Fowler WC, Hatch K.
    Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW, Muss HB, Thigpen JT, Homesley HD, Bundy B.
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [Abstract] [Full Text] [Related]

  • 3. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T, Shingleton H, Homesley H, LaGasse L, Blessing J.
    Cancer Treat Rep; 1979 Aug; 63(9-10):1549-55. PubMed ID: 498154
    [Abstract] [Full Text] [Related]

  • 4. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Van Le L, Waggoner S.
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS, Blessing JA, Boike G.
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
    Nezhat F, Wadler S, Muggia F, Mandeli J, Goldberg G, Rahaman J, Runowicz C, Murgo AJ, Gardner GJ.
    Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
    [Abstract] [Full Text] [Related]

  • 7. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG, Blessing JA, Arseneau J.
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Morris M, Blessing JA, Monk BJ, McGehee R, Moore DH.
    J Clin Oncol; 2004 Aug 15; 22(16):3340-4. PubMed ID: 15310778
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A, Blessing J, Bender D, Mannel R, Morgan M, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Mar 15; 100(3):586-90. PubMed ID: 16249022
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of cisplatin in cervical and endometrial carcinomas].
    Noda K, Takeuchi S, Kurihara S, Sugawa T, Kato T, Ikeda M, Kanazawa K, Tsutsui F, Yamamoto K, Umezu J.
    Gan To Kagaku Ryoho; 1987 Apr 15; 14(4):1129-35. PubMed ID: 3566307
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Muggia FM, Blessing JA, Waggoner S, Berek JS, Monk BJ, Sorosky J, Pearl ML.
    Gynecol Oncol; 2005 Jan 15; 96(1):108-11. PubMed ID: 15589588
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY, Blessing JA, Valea FA, McGehee R, Manetta A, Webster KD, Andersen WA.
    Gynecol Oncol; 1997 Dec 15; 67(3):255-8. PubMed ID: 9441772
    [Abstract] [Full Text] [Related]

  • 14. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E, Omrcen T, Novaković ZS, Jelavić TB, Prskalo T, Hrepić D, Hamm W.
    Gynecol Oncol; 2006 Nov 15; 103(2):494-9. PubMed ID: 16814371
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
    Fiorica J, Holloway R, Ndubisi B, Orr J, Grendys E, Boothby R, DeCesare S, LaPolla J, Hoffman M, Patel J.
    Gynecol Oncol; 2002 Apr 15; 85(1):89-94. PubMed ID: 11925125
    [Abstract] [Full Text] [Related]

  • 16. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
    Kastritis E, Bamias A, Efstathiou E, Gika D, Bozas G, Zorzou P, Sarris K, Papadimitriou C, Dimopoulos MA.
    Gynecol Oncol; 2005 Nov 15; 99(2):376-82. PubMed ID: 16051322
    [Abstract] [Full Text] [Related]

  • 17. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI, Blessing JA, Levenback C, Moore JL.
    Gynecol Oncol; 2001 May 15; 81(2):213-5. PubMed ID: 11354055
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, Barrett RJ, Gallup DG.
    Gynecol Oncol; 1994 Feb 15; 52(2):229-31. PubMed ID: 8314144
    [Abstract] [Full Text] [Related]

  • 19. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Bookman MA, Blessing JA, Hanjani P, Herzog TJ, Andersen WA.
    Gynecol Oncol; 2000 Jun 15; 77(3):446-9. PubMed ID: 10831357
    [Abstract] [Full Text] [Related]

  • 20. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T, Vance RB, Khansur T.
    Semin Oncol; 1995 Oct 15; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.